Management of Pulmonary Hypertension Associated with Left Heart Disease

被引：4

作者：

Franco, Veronica ^{[1
]}

机构：

[1] Ohio State Univ, Div Cardiovasc Dis, Pulm Hypertens Program, Adv Heart Failure LVAD & Transplantat Program, DHLRI Suite 200,473 West 12th Ave, Columbus, OH 43210 USA

来源：

HEART FAILURE CLINICS | 2018年 / 14卷 / 04期

关键词：

Hypertension; Heart failure; Ejection fraction; Right ventricular; Pulmonary hypertension; Pulmonary arterial hypertension; GUANYLATE-CYCLASE STIMULATOR; PRESERVED EJECTION FRACTION; VENTRICULAR ASSIST DEVICE; DOUBLE-BLIND; INTERNATIONAL SOCIETY; CLINICAL-OUTCOMES; PRESSURE-GRADIENT; LISTING CRITERIA; FLUID CHALLENGE; FAILURE;

D O I：

10.1016/j.hfc.2018.06.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary hypertension (PH) due to left heart disease, or WHO group 2 PH, is the most frequent cause of PH. It affects approximately 50% to 60% of patients with heart failure with preserved ejection fraction as well as 60% of those with heart failure with reduced ejection fraction and contributes significantly to disease progression and unfavorable outcomes. The diagnosis of PH is associated with poor prognosis and significant morbidity and mortality.

引用

页码：545 / +

页数：8

共 50 条

[31] Pulmonary hypertension due to left heart disease
Berthelot, Emmanuelle
Bailly, Minh Tam
El Hatimi, Safwane
Robard, Ingrid
Rezgui, Hatem
Bouchachi, Amir
Montani, David
Sitbon, Olivier
Chemla, Denis
Assayag, Patrick
ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (6-7) : 420 - 431
[32] Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease
Gillmeyer, Kari R.
Miller, Donald R.
Glickman, Mark E.
Qian, Shirley X.
Klings, Elizabeth S.
Maron, Bradley A.
Hanlon, Joseph T.
Rinne, Seppo T.
Wiener, Renda S.
PULMONARY CIRCULATION, 2021, 11 (01)
[33] Pulmonary hypertension associated with left heart disease (group 2)
Schmidt, Kai Helge
Bikou, Olympia
Blindt, Ruediger
Bruch, Leonhard
Felgendreher, Ralf
Hohenforst-Schmidt, Wolfgang
Holt, Stephan
Ladage, Dennis
Pfeuffer-Jovic, Elena
Rieth, Andreas
Schmeisser, Alexander
Schnitzler, Katharina
Stadler, Stefan
Steringer-Mascherbauer, Regina
Yogeswaran, Athiththan
Kuebler, Wolfgang M.
PNEUMOLOGIE, 2023, 77 (11): : 926 - 936
[34] Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis
Cao, Jacob Y.
Wales, Kathryn M.
Cordina, Rachael
Lau, Edmund M. T.
Celermajer, David S.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 213 - 220
[35] Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review
Kido, Kazuhiko
Coons, James C.
PHARMACOTHERAPY, 2019, 39 (09): : 929 - 945
[36] Pulmonary hypertension due to left heart disease: Recommendations of the Cologne Consensus Conference 2010
Rosenkranz, S.
Bonderman, D.
Buerke, M.
Felgendreher, R.
ten Freyhaus, H.
Gruenig, E.
de Haan, F.
Hammerstingl, C.
Harreuter, A.
Hohenforst-Schmidt, W.
Kindermann, I.
Kindermann, M.
Kleber, F. -X.
Kuckeland, M.
Kuebler, W. M.
Mertens, D.
Mitrovic, V.
Opitz, C.
Schmeisser, A.
Schulz, U.
Speich, R.
Zeh, W.
Weil, J.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 : S102 - S114
[37] Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure
Naeije, Robert
Gerges, Mario
Vachiery, Jean-Luc
Caravita, Sergio
Gerges, Christian
Lang, Irene M.
CIRCULATION-HEART FAILURE, 2017, 10 (09)
[38] Pulmonary hypertension in left heart disease
Guazzi, Marco
Galie, Nazzareno
EUROPEAN RESPIRATORY REVIEW, 2012, 21 (126) : 338 - 346
[39] Pulmonary hypertension in left heart disease
Mehra, Pratishtha
Mehta, Vimal
Sukhija, Rishi
Sinha, Anjan K.
Gupta, Mohit
Girish, M. P.
Aronow, Wilbert S.
ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (01) : 262 - 273
[40] Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease
Dragu, Robert
Hardak, Emilia
Ohanyan, Astghik
Adir, Yochai
Aronson, Doron
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 290 : 138 - 143

← 1 2 3 4 5 →